西氏

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000002  Size: 6 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000025  Size: 8 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000016  Size: 12 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000018  Size: 6 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000020  Size: 8 KB 网页链接

$西氏(WST)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000105770-26-000010  Act: 34  Size: 17 MB 网页链接

$西氏(WST)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0000105770-26-000005  Act: 34  Size: 4 MB 网页链接

$西氏(WST)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-26-026778  Act: 34  Size: 8 MB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000037  Size: 7 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000023  Size: 8 KB 网页链接

$西氏(WST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-26-026779  Act: 34  Size: 404 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000039  Size: 7 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000024  Size: 8 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000017  Size: 12 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000019  Size: 6 KB 网页链接

来源：环球市场播报
　　West Pharmaceutical（西氏医药）周四公布，受其专利产品需求强劲推动，公司第四季度业绩超出市场预期，并预计 2026 年全年利润将高于华尔街预期。该公司产品包括注射器及注射用药药筒等。
　　这家总部位于美国宾夕法尼亚州的企业股价在盘前交易中上涨 3.6%。...

$西氏(WST)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0000105770-26-000041  Act: 34  Size: 770 KB 网页链接

$西氏(WST)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-002606  Act: 34  Size: 7 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000043  Size: 6 KB 网页链接

$西氏(WST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000105770-26-000036  Size: 7 KB 网页链接